الفهرس | Only 14 pages are availabe for public view |
Abstract ystemic lupus Erythematosus (SLE) is a chronic multisystem autoimmune disease with a wide spectrum of manifestations, which is primarily affecting females and characterized by clinically heterogeneous manifestations of different organs (Carli et al., 2013). The etiology of SLE includes both genetic and environmental components with female sex strongly influencing pathogenesis. These factors lead to an irreversible break in immunological tolerance manifested by immune responses against endogenous nuclear antigens (Ruiz-Irastorza et al., 2010). The eye is frequently involved in SLE. The disease may cause ocular involvement by several mechanisms including immune complex deposition in the basement membrane of endothelial cells of the small blood vessels. Ocular complications have been reported in up to one-third of patients with SLE. Unlike other autoimmune diseases, which may have a predilection for either anterior or posterior segment of the eye, SLE may affect any structure of the eye and adnexa. The ocular findings in SLE are important because they may be the initial manifestation of the disease (Ostanek et al., 2007) Our study is cross sectional case control study which was carried out on 100 SLE patients fulfilling diagnosis according to Systemic Lupus International Collaborating Clinics (SLICC) 2012 classification criteria for SLE (Petri et al., 2012) and 30 age and sex matched normal controls. All patients were subjected to detailed medical history taking and thorough clinically and musculoskeletal examination with assessment of disease activity using SLEDAI score. Results of our study showed that about 46% of SLE patients had ocular manifestations. Dry eye and retinopathy were the most prevalent among SLE patients with each affecting 24% of them. 17% of the patients had reduced visual acuity. Cotton-wool spots were the most common retinal abnormal finding followed by other rare forms of retinopathy as vasculitis, attenuated blood vessels, papilledema and pale optic disc. SLE patients with ocular affection especially retinopathy had significantly higher levels of Anticardiolipin antibodies, Lupus Anticoagulant and also disease duration and SLEDAI score when compared to those patients without ocular affection. |